Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia

Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann

Blood Adv bloodadvances.2023012382.

https://doi.org/10.1182/bloodadvances.2023012382

Published: 2024

Includes: Supplemental data